Methods: Screening was undertaken in 2016 and 2018, using the PHQ9 and the GAD7, with reasons for non-participation identified. Lung function (LF), prescribed MH medication, contacts with the CF psychologist and the use of external MH care were documented. Results: 119/157 adult patients participated in MH screening (once n= 36; twice n= 83). Reasons for non-participation were varied: refusal, other needs, missed at clinic visit, transplantation, learning difficulties, psychiatric problems. 33/157 patients were prescribed MH medication: anxiolytics (8); antidepressants (AD)(8); sleep medication (4); combination sleep/AD (12); other (1). The prescribing doctors were: CF physician (19), psychiatrist (8), and GP (6). Of these, 8 patients did not participate in MH screening; 25 consulted the CF psychologist more than 3 times a year, 7 also had an external therapist (4 had screened ‘no symptoms’). Between 2016 …

Time spent in therapy: how to measure the burden of disease for cystic fibrosis / S. Costa, V. Galici, A. Gramegna, L. Graziano, F. Majo, I. Moschetti. - In: JOURNAL OF CYSTIC FIBROSIS. - ISSN 1569-1993. - 18:suppl. 1(2019 Jun 01), pp. S26-S26. ((Intervento presentato al convegno European Cystic Fibrosis Congress tenutosi a Liverpool nel 2019 [10.1016/S1569-1993(19)30199-7].

Time spent in therapy: how to measure the burden of disease for cystic fibrosis

A. Gramegna;
2019

Abstract

Methods: Screening was undertaken in 2016 and 2018, using the PHQ9 and the GAD7, with reasons for non-participation identified. Lung function (LF), prescribed MH medication, contacts with the CF psychologist and the use of external MH care were documented. Results: 119/157 adult patients participated in MH screening (once n= 36; twice n= 83). Reasons for non-participation were varied: refusal, other needs, missed at clinic visit, transplantation, learning difficulties, psychiatric problems. 33/157 patients were prescribed MH medication: anxiolytics (8); antidepressants (AD)(8); sleep medication (4); combination sleep/AD (12); other (1). The prescribing doctors were: CF physician (19), psychiatrist (8), and GP (6). Of these, 8 patients did not participate in MH screening; 25 consulted the CF psychologist more than 3 times a year, 7 also had an external therapist (4 had screened ‘no symptoms’). Between 2016 …
Settore MED/10 - Malattie dell'Apparato Respiratorio
1-giu-2019
https://www.cysticfibrosisjournal.com/article/S1569-1993(19)30199-7/abstract
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS1569199319301997.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 52.43 kB
Formato Adobe PDF
52.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/667589
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact